13:41 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASGprnewswire·Jul 23 at 12:41 PMPASG-6.48%SLP-5.00%
CRNX: Pipeline advances in acromegaly, CAH, and NETs, with strong financial runway into 2030Quartr·Jul 21 at 04:25 PMCRNX+0.14%
These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Whybenzinga_article·Jul 21 at 02:52 PMRGNX-0.21%ADCT-0.87%
Are CRNX, VEEE, NXTC, TCBK Obtaining Fair Deals for their Shareholders?PR Newswire·Jul 21 at 01:51 PMVEEE+21.59%NXTC+20.75%
Market Insider: EV Charging Realities, Pharma Breakouts, and Under-the-Radar MoversGlobal Report·Jul 21 at 04:13 AMALAR0.00%AUMN-2.76%
Vertex Pharmaceuticals (VRTX) Stock Trades Below Fair Value After Deal PlansSimplywall·Jul 20 at 08:14 PMVRTX+0.34%CRNX+0.14%
Crinetics Pharmaceuticals (CRNX) Stock Looks Fully Valued While Returns Stay Very StrongSimplywall·Jul 17 at 12:16 PMCRNX+0.14%
14:23 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--ESI, CRNX, SOLS, and PATKprnewswire·Jul 16 at 01:25 PMCRNX+0.14%SOLS+8.00%
Are CRNX, VEEE, ESI Obtaining Fair Deals for their Shareholders?Unusual Whales·Jul 14 at 03:11 PMESI+1.07%CRNX+0.14%
Crinetics rises after Vertex agrees to buy it for $10BUS Stock Market Update·Jul 13 at 06:31 PMCRNX+0.14%
Inside the AI Hardware Boom and Biotech's Next Mega-DealsGlobal Report·Jul 12 at 04:13 AMSKHY-7.47%CRNX+0.14%
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology PowerhouseMarket Beat·Jul 11 at 04:02 PMCRNX+0.14%VRTX+0.34%
